Expert insights. Personalized for you.
Part 1: How healthcare professionals can access the latest and most accurate information on medications. Access to accurate, up-to-date information on medications helps healthcare professionals make better decisions. MORE
Credit: Sherry Harbin/Purdue University WEST LAFAYETTE, Ind. – New technology from Purdue University innovators may help improve tissue restoration outcomes for people with breast cancer and other diseases or traumatic injuries. MORE
Merck will lend J&J the use of two separate facilities in the unusual agreement, which was brokered by the Biden administration and could help double supply of the one-dose shot MORE
The pipeline for dry eye disease drugs is beginning to heat up, with two biotechs announcing key developments, aiming to disrupt a market led by Allergan and Novartis. Novartis paid Takeda $3.4 MORE
SUMMARY: Almost every pharma company seems to be posting open digital marketing positions on LinkedIn but are they really hiring? A quick check of three open positions found that they “were on hold” due to budget constraints. MORE
Findings explain how plants use RNA to defend against fungal invaders Credit: Nicole Ward Gauthier/University of Kentucky New research reveals an essential step in scientists’ quest to create targeted, more eco-friendly fungicides that protect food crops. MORE
Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner. She spoke to pharmaphorum as part of our Patients Insights series. Like many “rare disease mums”, Christine is an accidental advocate. MORE
Credit: UTHSC Memphis, Tenn. March 2, 2021) – The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia. MORE
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 MORE
STI-2099 is a formulation of its antibody against COVID-19 that can be taken in a nasal spray. It is also evaluating the antibody in an intravenous form (STI-2020) in a Phase I trial MORE
Though a mid-stage study read out negative, Neurocrine still sees a path forward for the drug, which it licensed from Takeda last summer MORE
Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid. MORE
The acquisition marks a dramatic turnaround for Five Prime, which has in recent years struggled through setbacks, executive departures and layoffs MORE
Takeda will develop soticlestat, a first-in-class inhibitor of the enzyme cholesterol 24-hydroxylase (CH24H), as a potential treatment for developmental and epileptic encephalopathies MORE
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management. MORE
The company’s coming trials will also involve pregnant women and people whose immune systems are compromised. internal-essential Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Immune System Clinical Trials Vaccination and Immunization Babies and Infants Johnson & Johnson MORE
Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior. MORE
The agency's emergency clearance makes J&J's vaccine the third available in the U.S., adding much-needed reinforcements at a critical time MORE
SUMMARY: Trust is earned every day. Today, because of the Internet, a lot of attention is placed on day-to-day activities. Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. MORE
Scottsdale, AZ (March 2, 2021) – VirTrial today announced the general availability of SmartSignals eConsent, a PDF-based, clinical trial consent solution offering rapid implementation and a flexible, scalable, and lightweight design. MORE
Dry eye disease may sound innocuous, but it’s a condition that affects between 25 and 35 percent of individuals in the US, and pandemic-related lifestyle changes may be pushing that percentage up. MORE
SUMMARY: COVID-19 has killed many people worldwide, but how many really died from COVID, and how many died because they had an underlying chronic health problem as a major factor? We may never know, but we can not afford to do anything while our population becomes more obese and unhealthy. MORE
AstraZeneca, through its partnership with the Serum Institute of India, says it is the biggest initial COVID-19 vaccine supplier to COVAX. Markets & Regulations MORE
SUMMARY: According to Pew Internet “Despite antibiotics’ vital role in cancer care, companies have abandoned their development in favor of more profitable drugs. MORE
Since December, three drugmakers have withdrawn immunotherapies from indications previously granted fast-tracked approvals, suggestive of broader FDA concerns MORE
Credit: National Park Service To investigate humans’ impact on freshwater resources, scientists have now conducted the first global accounting of fluctuating water levels in Earth’s lakes and reservoirs – including ones previously too small to measure from space. MORE
Interim results from clinical trials suggested that Covaxin could be safe and effective, potentially removing one hurdle to New Delhi’s ambitious campaign to inoculate a vast population. MORE
New data may have serious implications for the development of vaccination strategies for COVID-19, particularly in individuals with obesity. Markets & Regulations MORE
The CRISPR biotech raised $115 million in a Series C financing aimed at advancing its engineered cell therapy research MORE
Bio Pharma Dive
MARCH 2, 2021
Merck will lend J&J the use of two separate facilities in the unusual agreement, which was brokered by the Biden administration and could help double supply of the one-dose shot
World of DTC Marketing
MARCH 4, 2021
SUMMARY: COVID-19 has killed many people worldwide, but how many really died from COVID, and how many died because they had an underlying chronic health problem as a major factor? We may never know, but we can not afford to do anything while our population becomes more obese and unhealthy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Phorum
MARCH 4, 2021
Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid.
Scienmag
MARCH 3, 2021
Credit: UTHSC Memphis, Tenn. March 2, 2021) – The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.
Bio Pharma Dive
FEBRUARY 27, 2021
The agency's emergency clearance makes J&J's vaccine the third available in the U.S., adding much-needed reinforcements at a critical time
World of DTC Marketing
MARCH 3, 2021
SUMMARY: According to Pew Internet “Despite antibiotics’ vital role in cancer care, companies have abandoned their development in favor of more profitable drugs.
NY Times
FEBRUARY 28, 2021
The company’s coming trials will also involve pregnant women and people whose immune systems are compromised. internal-essential Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Immune System Clinical Trials Vaccination and Immunization Babies and Infants Johnson & Johnson
Clinical Research Informer brings together the best content for pharmaceutical professionals from the widest variety of industry thought leaders.
Bio Pharma Dive
MARCH 2, 2021
Though a mid-stage study read out negative, Neurocrine still sees a path forward for the drug, which it licensed from Takeda last summer
World of DTC Marketing
MARCH 2, 2021
SUMMARY: Almost every pharma company seems to be posting open digital marketing positions on LinkedIn but are they really hiring? A quick check of three open positions found that they “were on hold” due to budget constraints.
NY Times
MARCH 4, 2021
Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.
Bio Pharma Dive
MARCH 3, 2021
A new agreement with Ovid Therapeutics has Takeda paying almost $200 million to secure global rights to soticlestat, an experimental treatment for certain brain diseases, including Dravet syndrome and Lennox Gastaut syndrome
World of DTC Marketing
MARCH 1, 2021
SUMMARY: Trust is earned every day. Today, because of the Internet, a lot of attention is placed on day-to-day activities. Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines.
ERT
MARCH 1, 2021
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management.
Scienmag
MARCH 3, 2021
Credit: National Park Service To investigate humans’ impact on freshwater resources, scientists have now conducted the first global accounting of fluctuating water levels in Earth’s lakes and reservoirs – including ones previously too small to measure from space.
Bio Pharma Dive
MARCH 2, 2021
Since December, three drugmakers have withdrawn immunotherapies from indications previously granted fast-tracked approvals, suggestive of broader FDA concerns
World of DTC Marketing
FEBRUARY 28, 2021
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7
NY Times
MARCH 4, 2021
Interim results from clinical trials suggested that Covaxin could be safe and effective, potentially removing one hurdle to New Delhi’s ambitious campaign to inoculate a vast population.
Scienmag
MARCH 2, 2021
New study points to potential widespread phagocytosis among green algae, suggests improved methodology in environmental microbiology Credit: N. Bock & E.
Bio Pharma Dive
MARCH 1, 2021
For marketers in the health space, cannabis and CBD consumers represent an audience that is in search of both alternative and conventional methods of well-being as their transformation from patient to participant accelerates
Pharma R&D Today
MARCH 2, 2021
Part 1: How healthcare professionals can access the latest and most accurate information on medications. Access to accurate, up-to-date information on medications helps healthcare professionals make better decisions.
BioSpace
MARCH 2, 2021
Takeda will develop soticlestat, a first-in-class inhibitor of the enzyme cholesterol 24-hydroxylase (CH24H), as a potential treatment for developmental and epileptic encephalopathies
Bio Pharma Dive
MARCH 4, 2021
The acquisition marks a dramatic turnaround for Five Prime, which has in recent years struggled through setbacks, executive departures and layoffs
XTalks
MARCH 1, 2021
Dry eye disease may sound innocuous, but it’s a condition that affects between 25 and 35 percent of individuals in the US, and pandemic-related lifestyle changes may be pushing that percentage up.
Pharma Phorum
MARCH 4, 2021
The pipeline for dry eye disease drugs is beginning to heat up, with two biotechs announcing key developments, aiming to disrupt a market led by Allergan and Novartis. Novartis paid Takeda $3.4
Scienmag
MARCH 4, 2021
Bio Pharma Dive
MARCH 3, 2021
The CRISPR biotech raised $115 million in a Series C financing aimed at advancing its engineered cell therapy research
BioTech 365
MARCH 5, 2021
DIH partners with Reha Technology DIH partners with Reha Technology A strategic partnership to provide market leading solutions in the lower extremities rehabilitation.
BioPharma Reporter
MARCH 2, 2021
AstraZeneca, through its partnership with the Serum Institute of India, says it is the biggest initial COVID-19 vaccine supplier to COVAX. Markets & Regulations
Scienmag
MARCH 4, 2021
Findings explain how plants use RNA to defend against fungal invaders Credit: Nicole Ward Gauthier/University of Kentucky New research reveals an essential step in scientists’ quest to create targeted, more eco-friendly fungicides that protect food crops.
Bio Pharma Dive
MARCH 4, 2021
The results are a boost for Lilly's drug, tirzepatide, which is being prepared for regulatory submissions later this year. But long-term heart data won't be available for some time
VirTrial
MARCH 1, 2021
Scottsdale, AZ (March 2, 2021) – VirTrial today announced the general availability of SmartSignals eConsent, a PDF-based, clinical trial consent solution offering rapid implementation and a flexible, scalable, and lightweight design.
BioPharma Reporter
MARCH 1, 2021
New data may have serious implications for the development of vaccination strategies for COVID-19, particularly in individuals with obesity. Markets & Regulations
Scienmag
MARCH 1, 2021
Credit: Sherry Harbin/Purdue University WEST LAFAYETTE, Ind. – New technology from Purdue University innovators may help improve tissue restoration outcomes for people with breast cancer and other diseases or traumatic injuries.
Bio Pharma Dive
MARCH 3, 2021
The results could help baricitinib become the first treatment for alopecia areata, a leading cause of hair loss. Safety concerns have diminished the drug's prospects in arthritis, however
BioSpace
MARCH 2, 2021
STI-2099 is a formulation of its antibody against COVID-19 that can be taken in a nasal spray. It is also evaluating the antibody in an intravenous form (STI-2020) in a Phase I trial
63 
Let's personalize your content